novocure-Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet

NovoCure (NVCR) closed the last trading session at $18.91, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 25.71 indicates a 36% upside potential. The mean estimate comprises seven short-term price targets with a standard deviation of $7.16. While the lowest estimate of$ 18 indicates a 4.8% decline from the current price level, the most optimistic analyst expects the ...